Vol 6 No 3 (2022): Proceedings of Anticancer Research
Proceedings of Anticancer Research
Published on May 20, 2022

Click Here to Download Full Issue

Progress in the Use of Natural Products for the Treatment of Lung Cancer

Song Teng, Zhuoxuan Liang, Tong Lyu, Yuntao Yang, Mengying Gou, Xiaoqiong He 1-5
DOI: 10.26689/par.v6i3.3727

Treatment of Melanoma: Current Status and Prospects

Zhiyou Ye 6-10
DOI: 10.26689/par.v6i3.3875

Experience in Treating Viral Myocarditis with Master Lei’s Huoxue Decoction

Guoxing Sun, Hong Fan 11-16
DOI: 10.26689/par.v6i3.3882

Research Progress in the Application of Lycium Barbarum Polysaccharide in Ophthalmic Diseases

Yanna Lin, Huiqin Wu 17-22
DOI: 10.26689/par.v6i3.3885

Lei Genping’s Experience in Treating Recurrent Urinary Tract Infection

Lin Xia, Genping Lei 23-27
DOI: 10.26689/par.v6i3.3886

A Summary of Lei Genping’s Experience in the Treatment of Chronic Nephritis

Yue Zhang, Genping Lei 28-33
DOI: 10.26689/par.v6i3.3884

Are M1 and M2 macrophages Effectual Players in Pathological Conditions?

Elham Abdollahi, Nafiseh Saghafi, Malihe Hasanzade 34-41
DOI: 10.26689/par.v6i3.3962

Research Progress of Traditional Chinese and Western Medicine in Hyperthyroid Heart Disease

Shuyu Li, Mingjun Zhao 42-47
DOI: 10.26689/par.v6i3.3984

Clinical Efficacy of Lenalidomide Combined with Cyclophosphamide and Dexamethasone in the Treatment of Multiple Myeloma

Yudi Miao 48-52
DOI: 10.26689/par.v6i3.3998

Inhibition of RNaseH2A Induces Fas-Regulated Programmed Cell Death in Hepatoma Cells

Xiaowei Chang, Yu Cai, Pu Yan, Wujun Li 53-62
DOI: 10.26689/par.v6i3.4011

A Study on the Effectiveness of Decitabine Combined with a Half-Dose Priming Regimen in the Treatment of Elderly Patients with Acute Myeloid Leukemia

Ying Gao, Lan Li, Xingxing Hu, Yudi Miao 63-68
DOI: 10.26689/par.v6i3.3999

Clinical Value of Peripheral Blood Circulating Tumor Cells and Cell-Free DNA Combined Detection in Triple-Negative Breast Cancer

Jirui Sun, Shuangqui Ma, Hong Chen, Huijuan Geng, Jinku Zhang 69-73
DOI: 10.26689/par.v6i3.4019